119-s2332

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2332 Introduced in Senate

    (IS) ]

<DOC>

119th CONGRESS
 1st Session
 S. 2332

To require research with respect to fentanyl and xylazine test strips, 
to authorize the use of grant funds for such test strips, and for other 
 purposes.

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 July 17, 2025

Ms. Hassan (for herself and Mr. Cornyn) introduced the following bill; 
 which was read twice and referred to the Committee on Health, 
 Education, Labor, and Pensions

_______________________________________________________________________

 A BILL

To require research with respect to fentanyl and xylazine test strips, 
to authorize the use of grant funds for such test strips, and for other 
 purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Advancing Lifesaving Efforts with 
Rapid Test strips for Communities Act'' or the ``ALERT Communities 
Act''.

SEC. 2. GRANT PROGRAM FROM STATE AND TRIBAL RESPONSE TO OPIOID USE 
 DISORDERS.

 The activities carried out pursuant to 

section 1003

    (b)

    (4)
        (A) of the 
21st Century Cures Act (42 U.S.C. 290ee-3 note) may include 
facilitating access to products used to prevent overdose deaths by 
detecting the presence of one or more substances, such as fentanyl and 
xylazine test strips, to the extent the purchase and possession of such 
products is consistent with Federal and State law.

SEC. 3. FIRST RESPONDER TRAINING.

 

Section 546
            (c) of the Public Health Service Act (42 U.S.C. 290ee-
1
            (c) ) is amended--

    (1) in paragraph

    (3) , by striking ``; and'' and inserting a 
 semicolon;

    (2) in paragraph

    (4) , by striking the period and inserting 
 ``; and''; and

    (3) by adding at the end the following:
 ``

    (5) train and provide resources for first responders and 
 members of other relevant community sectors on carrying and 
 facilitating access to fentanyl or xylazine test strips.''.

SEC. 4. RESEARCH AND MARKETING FRAMEWORKS FOR TEST STRIP TECHNOLOGY.

 The Secretary of Health and Human Services, in consultation with 
the Director of the National Institutes of Health, the Director of the 
Office of National Drug Control Policy, the Commissioner of Food and 
Drugs, and the Administrator of the Drug Enforcement Administration, 
shall develop and make publicly available research and marketing 
frameworks for developing, improving, and evaluating test strip 
technology for detecting fentanyl and other dangerous substances. Such 
frameworks shall--

    (1) include standards and guidance for manufacturers 
 seeking to develop and test new test strip technology;

    (2) emphasize bringing new test strip technology intended 
 for testing human specimens in clinical settings to support on-
 site clinical decision-making; and

    (3) include guidance on available authorization pathways 
 for test strips described in paragraphs

    (1) and

    (2) .

SEC. 5. STUDY ON FENTANYL TEST STRIP INTERVENTIONS.

 The Secretary of Health and Human Services shall--

    (1) conduct a study on the impact of the availability, 
 accessibility, and usage of drug checking supplies, including 
 test strips, on frequency of overdose, overdose deaths, and 
 engagement in substance use disorder treatment; and

    (2) not later than 2 years after the date of enactment of 
 this Act, submit to Congress a report on the study conducted 
 under paragraph

    (1) .
 <all>